Delivery Order SPE2DB20D1109-SPE2DB23FQ02H
Award Date
9/27/23
Potential Completion Date
9/28/23
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.20 firm-fixed price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a ceiling value of $2,076.90 and a completion date of March 19, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award, valued at $2,637.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order for the procurement of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, with a ceiling value of $3,353.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through July 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $3,393.60 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a period of performance through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $1,177.99 and a period of performance through July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 for the delivery of a...
The federal contract award is for the delivery of CATHFLO ACTIVASE 2 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,070.45 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 19, 2025, with a completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,382.99 for the medical product "CATHFLO ACTIVASE 2 MG VIALS". The contract is a firm-fixed price arrangement with an ultimate completion date of October 23, 2024. The prime contractor, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.55, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 8, 2024. This contract award is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,832.35 Firm Fixed Price Delivery Order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through May 15, 2023. The award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...